Related Experiment Video
Updated: Feb 18, 2026

Magnetic Resonance Derived Myocardial Strain Assessment Using Feature Tracking
Published on: February 12, 2011
Prognostic Stratification of Patients With ST-Segment-Elevation Myocardial Infarction (PROSPECT): A Cardiac Magnetic
Gianluca Pontone1, Andrea I Guaricci2, Daniele Andreini2
1From the Centro Cardiologico Monzino, IRCCS, Milan, Italy (G.P., D.A., M.G., A.B., L.F., S.M., E.C., A.A., A.F., M.E.M., M.V., N.C., G.M., P.A., A.L.B., M.P.); Yonsei University Health System, Seoul, South Korea (G.P.); Department of Emergency and Organ Transplantation, Institute of Cardiovascular Disease, University Hospital Policlinico Consorziale of Bari, Italy (A.I.G.); Department of Medical and Surgical Sciences, University of Foggia, Italy (A.I.G.); Dipartimento di Cardiologia, Policlinico Universitario Paolo Giaccone, Palermo, Italy (G.F., P.C., F.F.); Centro Medico Polispecialistico, Torre Annunziata (Naples), Italy (G.M.); Istituto di Management, Scuola Superiore Sant'Anna, Pisa, Italy (V.L.); Multimodality Cardiac Imaging Section, IRCCS, Policlinico San Donato, Milan, Italy (S.P.); Loyola University of Chicago, IL (M.G.R.); Edward Hines Jr. Veterans Administration Hospital, IL (M.G.R.); Luigi Sacco Department of Biomedical and Clinical Sciences (A.L.B.) and Department of Cardiovascular Sciences and Community Health (D.A., P.A.), University of Milan, Italy; and Division of Cardiology, Centre of Cardiac Magnetic Resonance, University Hospital Lausanne, Switzerland (P.G.M.). gianluca.pontone@ccfm.it.
Insights
A new Cardiac Magnetic Resonance (CMR) score offers improved prognostic stratification for ST-segment-elevation myocardial infarction patients. This CMR score provides additional benefits over standard GRACE scores and LVEF measurements for predicting major adverse cardiac events.
Area of Science:
- Cardiology
- Medical Imaging
- Prognostics
Background:
- ST-segment-elevation myocardial infarction (STEMI) management relies on risk stratification.
- Cardiac Magnetic Resonance (CMR) assesses myocardial damage, but its prognostic value beyond standard methods needs clarification.
Purpose of the Study:
- To evaluate the incremental prognostic benefit of a novel CMR score.
- To compare the CMR score's performance against the Global Registry of Acute Coronary Events (GRACE) score and transthoracic echocardiography-derived left ventricular ejection fraction (LVEF).
Main Methods:
- A cohort of 209 STEMI patients underwent CMR and echocardiography post-primary percutaneous coronary intervention.
- A weighted CMR score was developed using CMR-LVEF, myocardial salvage index, microvascular obstruction, and myocardial hemorrhage.
- Major adverse cardiac events (MACE) were tracked over a mean follow-up of 2.5 years.
Main Results:
- The CMR score independently predicted MACE (HR, 1.867 per SD increase; P<0.001).
- Patients with MACE had higher GRACE scores, lower LVEF, lower myocardial salvage index, and more microvascular obstruction and hemorrhage.
- The CMR score demonstrated the highest net reclassification improvement compared to GRACE score and echocardiography-LVEF.
Conclusions:
- The developed CMR score offers superior prognostic stratification for STEMI patients.
- This CMR score may significantly influence clinical decision-making and patient management strategies.
Background:
Cardiac magnetic resonance (CMR) is a robust tool to evaluate left ventricular ejection fraction (LVEF), myocardial salvage index, microvascular obstruction, and myocardial hemorrhage in patients with ST-segment-elevation myocardial infarction. We evaluated the additional prognostic benefit of a CMR score over standard prognostic stratification with global registry of acute coronary events (GRACE) score and transthoracic echocardiography LVEF measurement.
Methods And Results:
Two hundred nine consecutive patients with ST-segment-elevation myocardial infarction (age, 61.4±11.4 years; 162 men) underwent transthoracic echocardiography and CMR after succesful primary percutaneous coronary intervention. Major adverse cardiac events (MACE) were assessed at a mean follow-up of 2.5±1.2 years. MACE occurred in 24 (12%) patients who at baseline showed higher GRACE risk score (P<0.01), lower LVEF with both transthoracic echocardiography and CMR, lower myocardial salvage index, and higher per-patient myocardial hemorrhage and microvascular obstruction prevalence and amount as compared with patients without MACE (P<0.01). The best cut-off values of transthoracic echocardiography-LVEF, CMR-LVEF, myocardial salvage index, and microvascular obstruction to predict MACE were 46.7%, 37.5%, 0.4, and 2.6% of left ventricular mass, respectively. Accordingly, a weighted CMR score, including the following 4 variables (CMR-LVEF, myocardial salvage index, microvascular obstruction, and myocardial hemorrhage), with a maximum of 17 points was calculated and included in the multivariable analysis showing that only CMR score (hazard ratio, 1.867 per SD increase [1.311-2.658]; P<0.001) was independently associated with MACE with the highest net reclassification improvement as compared to GRACE score and transthoracic echocardiography-LVEF measurement.
Conclusions:
CMR score provides incremental prognostic stratification as compared with GRACE score and transthoracic echocardiography-LVEF and may impact the management of patients with ST-segment-elevation myocardial infarction.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System IV: CMRI
Acute Coronary Syndrome I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Heart Failure IV: Classification and Diagnostic Evaluation

